Plus Therapeutics updates Nasdaq listing; panel grants continued listing with conditions

PLUS THERAPEUTICS, INC.

Nasdaq panel granted continued listing; must demonstrate $2.5M stockholders' equity compliance by Aug 14, 2025.
Must also meet $1.00 bid price for 10 consecutive days by Sep 8, 2025.
Company reported stockholders' deficit of $23.6M as of March 31, 2025, triggering delisting notice.
Hearing held July 15, 2025; panel decision issued July 22, 2025.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-179382
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2025-08-13T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.327458+00:00
generated_at: 2026-05-17T13:51:01.980386+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: neutral
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-179382
json_url: https://secwatch.observer/filing/0001193125-25-179382.json
markdown_url: https://secwatch.observer/filing/0001193125-25-179382.md
text_url: https://secwatch.observer/filing/0001193125-25-179382.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525179382/0001193125-25-179382-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525179382/d930191d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-179382

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.